DNA

Zymo Research Announces Strategic Partnership with biomodal to Deliver Next-Gen Multiomic Insights

IRVINE, Calif., Nov. 18, 2025 /PRNewswire/ -- Zymo Research, a global leader in next-generation sequencing (NGS), has entered a strategic…

2 weeks ago

Freenome Announces Exclusive Agreement with Roche to Expand Technology Collaboration and Develop and Commercialize Cancer Screening Tests Outside the U.S.

– Partnership focuses on "kitted" tests in ex-U.S. markets, enabling accelerated access through a decentralized model – – Deal potentially…

2 weeks ago

Akari Therapeutics Appoints Biotech Finance Leader, Kameel D. Farag as Interim Chief Financial Officer

More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and…

2 weeks ago

Mainz Biomed and OncoVanguard8 Enter into Agreement to bring ColoAlert to South America

OncoVanguard8 is a leading service provider for innovative healthcare products for insurance companies operating in Peru, Colombia and EcuadorBERKELEY, Calif.…

2 weeks ago

INmune Bio Announces Two Presentations at the Upcoming 18th Annual CTAD Conference

Boca Raton, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company,…

2 weeks ago

Emergent BioSolutions Marks 10-Year Anniversary of the U.S. FDA Approval of NARCAN® Nasal Spray and Reinforces its Commitment to Increasing Naloxone Access

GAITHERSBURG, Md., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Today Emergent BioSolutions (NYSE: EBS) recognizes the 10-year anniversary of the U.S.…

2 weeks ago

ProPhase Labs, Inc. to Present Third Quarter 2025 Financial Results on November 19

UNIONDALE, NY, Nov. 18, 2025 (GLOBE NEWSWIRE) -- ProPhase Labs Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation…

2 weeks ago

Rakovina Therapeutics’ President & CSO to Present and Join Expert Panel at the 9th Annual DDR Inhibitors Summit

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (“Rakovina” or the “Company”) (TSX-V: RKV)(FSE: 7JO0) a…

2 weeks ago

AI in Personalized Nutrition Market to Reach USD 4.26 Billion by 2032, Driven by Predictive Analytics, Deep Learning & Real-Time Dietary Intelligence | DataM Intelligence

AUSTIN, Texas and TOKYO, Nov. 17, 2025 /PRNewswire/ -- According to DataM Intelligence, the AI in Personalized Nutrition Market Size reached…

3 weeks ago

OBI-902 Has Been Granted by US FDA for Orphan Drug Designation for the Treatment of Cholangiocarcinoma

OBI-902 is the first ADC utilizing OBI's proprietary GlycOBI® glycan-based ADC enabling technology for evaluation of safety and efficacy in…

3 weeks ago